Biomarin Pharmaceutical Inc (BMRN) — Financial Flexibility Index
Biomarin Pharmaceutical Inc (BMRN) has a Financial Flexibility Index of 0.09x as of December 2025. Free cash flow of $140.37 Million (operating CF $99.64 Million minus capex $40.72 Million) represents 0% of total liabilities ($1.51 Billion). Also explore net asset growth rate of Biomarin Pharmaceutical Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biomarin Pharmaceutical Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Biomarin Pharmaceutical Inc across 28 annual periods. Check BMRN strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Biomarin Pharmaceutical Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Biomarin Pharmaceutical Inc. For the full company profile including market capitalisation, see Biomarin Pharmaceutical Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $931.03 Million | $827.99 Million | $1.51 Billion | ▲ +22.7% |
| 2024 | 0.50x | $670.26 Million | $572.84 Million | $1.33 Billion | ▲ +271.9% |
| 2023 | 0.14x | $255.95 Million | $159.26 Million | $1.89 Billion | ▼ -19.2% |
| 2022 | 0.17x | $296.86 Million | $175.90 Million | $1.77 Billion | ▼ -31.5% |
| 2021 | 0.24x | $423.76 Million | $304.54 Million | $1.73 Billion | ▲ +91.2% |
| 2020 | 0.13x | $222.88 Million | $85.36 Million | $1.74 Billion | ▲ +3.8% |
| 2019 | 0.12x | $193.29 Million | $48.26 Million | $1.57 Billion | ▲ +9.2% |
| 2018 | 0.11x | $164.83 Million | $20.21 Million | $1.46 Billion | ▲ +8.2% |
| 2017 | 0.10x | $190.46 Million | $-8.76 Million | $1.82 Billion | ▲ +265.2% |
| 2016 | -0.06x | $-79.46 Million | $-227.84 Million | $1.26 Billion | ▼ -1507.6% |
| 2015 | 0.00x | $5.96 Million | $-221.69 Million | $1.33 Billion | ▼ -90.5% |
| 2014 | 0.05x | $45.30 Million | $-73.54 Million | $962.56 Million | ▲ +674.0% |
| 2013 | 0.01x | $5.49 Million | $-59.63 Million | $903.02 Million | ▼ -94.6% |
| 2012 | 0.11x | $62.18 Million | $17.61 Million | $552.58 Million | ▼ -65.3% |
| 2011 | 0.32x | $172.97 Million | $18.75 Million | $532.66 Million | ▲ +159.6% |
| 2010 | 0.13x | $68.21 Million | $18.75 Million | $545.37 Million | ▼ -58.1% |
| 2009 | 0.30x | $177.53 Million | $87.73 Million | $594.98 Million | ▲ +298.3% |
| 2008 | 0.07x | $47.19 Million | $-9.18 Million | $630.02 Million | ▲ +489.1% |
| 2007 | -0.02x | $-12.08 Million | $-34.49 Million | $627.55 Million | ▲ +73.9% |
| 2006 | -0.07x | $-25.51 Million | $-50.09 Million | $345.63 Million | ▲ +66.3% |
| 2005 | -0.22x | $-59.72 Million | $-62.68 Million | $272.76 Million | ▼ -60.5% |
| 2004 | -0.14x | $-41.07 Million | $-65.14 Million | $300.94 Million | ▲ +72.5% |
| 2003 | -0.50x | $-68.82 Million | $-74.80 Million | $138.49 Million | ▲ +87.7% |
| 2002 | -4.04x | $-48.73 Million | $-53.59 Million | $12.07 Million | ▼ -842.3% |
| 2001 | -0.43x | $-5.25 Million | $-23.07 Million | $12.26 Million | ▲ +67.5% |
| 2000 | -1.32x | $-9.14 Million | $-12.90 Million | $6.94 Million | ▼ -168.1% |
| 1999 | 1.93x | $10.00 Million | $-12.94 Million | $5.17 Million | ▲ +340.1% |
| 1998 | -0.81x | $-1.70 Million | $-8.10 Million | $2.11 Million | — |